FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945430070> ?p ?o ?g. }

• W2945430070 endingPage "183" @default.
• W2945430070 startingPage "176" @default.
• W2945430070 abstract "Objective To investigate the adoption of abiraterone and enzalutamide by urologists. Abiraterone and enzalutamide are oral therapies approved for the treatment of metastatic castration-resistant prostate cancer, a disease most commonly treated by medical oncologists. Methods Using the Medicare Part D Public Use Files from 2013 to 2016, we identified total abiraterone and enzalutamide prescriptions 2013-2016 and urologists who prescribed moderate to high volumes of these drugs. We then characterized the urologist practices of those urologists according to practice context (eg, single-specialty group) using data from the Centers for Medicare and Medicaid Services, and the geographic distribution of those providers. Results We found abiraterone prescriptions increased from 71,423 in 2013 to a peak of 100,371 in 2015 and enzalutamide prescriptions continued to increase from 29,572 in 2013 to 100,980 in 2016. Prescriptions by urologists increased between 2013 and 2016 while prescriptions by other specialties plateaued. The number of moderate-high prescribing urologists increased from 98 (abiraterone) and 22 (enzalutamide) in 2013, to 301 (abiraterone) and 671 (enzalutamide) by 2016 with 1063 unique urologists prescribing moderate-high volumes of either drug between 2013 and 2016. Among urologists who prescribe androgen deprivation therapy, 5% were moderate-high prescribers of abiraterone and 12% of enzalutamide in 2016. The majority of moderate-high prescribing urologists were in single-specialty groups (70%). Conclusion Urologists are increasingly prescribing oral therapies for metastatic castration-resistant prostate cancer. Understanding the distribution of urologists specializing in castration-resistant prostate cancer therapeutics will help guide future interventions to optimize the care for this important patient population." @default.
• W2945430070 created "2019-05-29" @default.
• W2945430070 creator A5000093901 @default.
• W2945430070 creator A5003694149 @default.
• W2945430070 creator A5007202399 @default.
• W2945430070 creator A5008395825 @default.
• W2945430070 creator A5016126152 @default.
• W2945430070 creator A5066461876 @default.
• W2945430070 creator A5072323801 @default.
• W2945430070 creator A5082554505 @default.
• W2945430070 creator A5084644000 @default.
• W2945430070 date "2019-09-01" @default.
• W2945430070 modified "2023-10-14" @default.
• W2945430070 title "Adoption of Abiraterone and Enzalutamide by Urologists" @default.
• W2945430070 cites W1983909168 @default.
• W2945430070 cites W2028323896 @default.
• W2945430070 cites W2055592964 @default.
• W2945430070 cites W2110534364 @default.
• W2945430070 cites W2113952199 @default.
• W2945430070 cites W2137467802 @default.
• W2945430070 cites W2140756266 @default.
• W2945430070 cites W2148643283 @default.
• W2945430070 cites W2166918329 @default.
• W2945430070 cites W2620746860 @default.
• W2945430070 cites W2620798309 @default.
• W2945430070 cites W2634134889 @default.
• W2945430070 cites W2774840047 @default.
• W2945430070 cites W2792086148 @default.
• W2945430070 cites W2794681317 @default.
• W2945430070 cites W2810806599 @default.
• W2945430070 cites W2935880623 @default.
• W2945430070 cites W4252724219 @default.
• W2945430070 cites W1995798492 @default.
• W2945430070 doi "https://doi.org/10.1016/j.urology.2019.05.012" @default.
• W2945430070 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6711811" @default.
• W2945430070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31136769" @default.
• W2945430070 hasPublicationYear "2019" @default.
• W2945430070 type Work @default.
• W2945430070 sameAs 2945430070 @default.
• W2945430070 citedByCount "18" @default.
• W2945430070 countsByYear W29454300702020 @default.
• W2945430070 countsByYear W29454300702021 @default.
• W2945430070 countsByYear W29454300702022 @default.
• W2945430070 countsByYear W29454300702023 @default.
• W2945430070 crossrefType "journal-article" @default.
• W2945430070 hasAuthorship W2945430070A5000093901 @default.
• W2945430070 hasAuthorship W2945430070A5003694149 @default.
• W2945430070 hasAuthorship W2945430070A5007202399 @default.
• W2945430070 hasAuthorship W2945430070A5008395825 @default.
• W2945430070 hasAuthorship W2945430070A5016126152 @default.
• W2945430070 hasAuthorship W2945430070A5066461876 @default.
• W2945430070 hasAuthorship W2945430070A5072323801 @default.
• W2945430070 hasAuthorship W2945430070A5082554505 @default.
• W2945430070 hasAuthorship W2945430070A5084644000 @default.
• W2945430070 hasBestOaLocation W29454300702 @default.
• W2945430070 hasConcept C121608353 @default.
• W2945430070 hasConcept C126322002 @default.
• W2945430070 hasConcept C126894567 @default.
• W2945430070 hasConcept C143998085 @default.
• W2945430070 hasConcept C20387591 @default.
• W2945430070 hasConcept C2426938 @default.
• W2945430070 hasConcept C2775832370 @default.
• W2945430070 hasConcept C2776421732 @default.
• W2945430070 hasConcept C2776551883 @default.
• W2945430070 hasConcept C2777899217 @default.
• W2945430070 hasConcept C2780192828 @default.
• W2945430070 hasConcept C2781190966 @default.
• W2945430070 hasConcept C29456083 @default.
• W2945430070 hasConcept C512399662 @default.
• W2945430070 hasConcept C61367390 @default.
• W2945430070 hasConcept C71924100 @default.
• W2945430070 hasConcept C98274493 @default.
• W2945430070 hasConceptScore W2945430070C121608353 @default.
• W2945430070 hasConceptScore W2945430070C126322002 @default.
• W2945430070 hasConceptScore W2945430070C126894567 @default.
• W2945430070 hasConceptScore W2945430070C143998085 @default.
• W2945430070 hasConceptScore W2945430070C20387591 @default.
• W2945430070 hasConceptScore W2945430070C2426938 @default.
• W2945430070 hasConceptScore W2945430070C2775832370 @default.
• W2945430070 hasConceptScore W2945430070C2776421732 @default.
• W2945430070 hasConceptScore W2945430070C2776551883 @default.
• W2945430070 hasConceptScore W2945430070C2777899217 @default.
• W2945430070 hasConceptScore W2945430070C2780192828 @default.
• W2945430070 hasConceptScore W2945430070C2781190966 @default.
• W2945430070 hasConceptScore W2945430070C29456083 @default.
• W2945430070 hasConceptScore W2945430070C512399662 @default.
• W2945430070 hasConceptScore W2945430070C61367390 @default.
• W2945430070 hasConceptScore W2945430070C71924100 @default.
• W2945430070 hasConceptScore W2945430070C98274493 @default.
• W2945430070 hasFunder F4320332177 @default.
• W2945430070 hasFunder F4320337351 @default.
• W2945430070 hasLocation W29454300701 @default.
• W2945430070 hasLocation W29454300702 @default.
• W2945430070 hasOpenAccess W2945430070 @default.
• W2945430070 hasPrimaryLocation W29454300701 @default.
• W2945430070 hasRelatedWork W122177069 @default.
• W2945430070 hasRelatedWork W2400161037 @default.
• W2945430070 hasRelatedWork W2540877368 @default.

• next